| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/21/1995 | WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 09/21/1995 | WO1995025166A1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 09/21/1995 | WO1995025165A1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
| 09/21/1995 | WO1995025164A1 Blood-borne mesenchymal cells |
| 09/21/1995 | WO1995025125A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | WO1995025114A1 Plant peptide transport gene |
| 09/21/1995 | WO1995024928A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | WO1995024926A1 Formulation for use in inducing cytotoxic t-cells |
| 09/21/1995 | WO1995024925A1 Cytotoxic t-cell epitopes |
| 09/21/1995 | WO1995024915A1 Product and process for regulating signal transduction pathways |
| 09/21/1995 | WO1995021858A3 Mosaic polypeptide and methods for detecting the hepatitis e virus |
| 09/21/1995 | WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
| 09/21/1995 | WO1995020663A3 THERMOSTABLE VARIANTS OF NEUTRAL PROTEASES OF BACILLUS STEAROTHERMOPHILUS AND $i(BACILLUS THERMOPROTEOLYTICUS) |
| 09/21/1995 | WO1995018826A3 Purified primate ctla-8 antigens and related reagents |
| 09/21/1995 | DE4424171A1 Verwendung von rekombinantem Inhibitor aus Erythrina caffra zur Reinigung von Serinproteasen Use of recombinant inhibitor from Erythrina caffra for the purification of serine proteases |
| 09/21/1995 | DE4409436A1 Verfahren zur Bearbeitung von Nukleinsäuren Method for processing nucleic acids |
| 09/21/1995 | CA2207851A1 Plant peptide transport gene |
| 09/21/1995 | CA2187781A1 Methods for treatment or diagnosis of diseases or conditions associated with abnormal signal transduction |
| 09/21/1995 | CA2185671A1 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 09/21/1995 | CA2185540A1 Formulation for use in inducing cytotoxic t-cells |
| 09/21/1995 | CA2185539A1 Blood-borne mesenchymal cells |
| 09/21/1995 | CA2185446A1 Methods for identifying inhibitors of integrin activation |
| 09/21/1995 | CA2185341A1 Dna encoding cai resistance proteins and uses thereof |
| 09/21/1995 | CA2184631A1 Product and process for regulating signal transduction pathways |
| 09/20/1995 | EP0672757A1 Functional assay method for the identification of thrombin receptor antagonists |
| 09/20/1995 | EP0672754A1 Plant virus vector, plasmid, method of expressing foreign gene, and method of acquiring foreign gene product |
| 09/20/1995 | EP0672753A1 Multicloning vector, expression vector, and production of foreign protein with expression vector |
| 09/20/1995 | EP0672752A1 Method of transforming monocotyledon by using scutellum of immature embryo |
| 09/20/1995 | EP0672751A1 Gene macromolecule reaction method and apparatus therefor |
| 09/20/1995 | EP0672707A2 Microencapsulated curing agent for thermosetting resin compositions |
| 09/20/1995 | EP0672685A2 Monoclonal antibody |
| 09/20/1995 | EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein |
| 09/20/1995 | EP0672681A1 Novel antitumor peptide |
| 09/20/1995 | EP0672677A2 Polyamide-oligonucleotide derivatives, their production and use |
| 09/20/1995 | EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 09/20/1995 | EP0672193A1 Oligonucleotides having a conserved g 4? core sequence |
| 09/20/1995 | EP0672191A1 Quantitative detection of macromolecules with fluorescent oligonucleotides |
| 09/20/1995 | EP0672190A1 Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |
| 09/20/1995 | EP0672189A1 A method of processing nucleic acid samples |
| 09/20/1995 | EP0672188A1 Method for selecting nucleic acids on the basis of structure |
| 09/20/1995 | EP0672186A1 Improved strand displacement assay and complex useful therefor |
| 09/20/1995 | EP0672182A1 Genomic mismatch scanning |
| 09/20/1995 | EP0672181A1 Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor |
| 09/20/1995 | EP0672180A1 Oligonucleotide modulation of protein kinase c |
| 09/20/1995 | EP0672178A1 Oligonucleotide modulation of cell growth |
| 09/20/1995 | EP0672176A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 09/20/1995 | EP0672175A1 Hav probes for use in solution phase sandwich hybridization assays |
| 09/20/1995 | EP0672174A1 Htlv-1 probes for use in solution phase sandwich hybridization assays |
| 09/20/1995 | EP0672171A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers which comprise purine base analogs |
| 09/20/1995 | EP0672160A1 Activating expression of an amplifying endogenous gene by homologous recombination |
| 09/20/1995 | EP0672159A1 In vivo homologous sequence targeting in eukaryotic cells |
| 09/20/1995 | EP0672158A1 Virus with modified binding moiety specific for the target cells |
| 09/20/1995 | EP0672157A1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 09/20/1995 | EP0672156A1 Bovine heat shock promoter and uses thereof |
| 09/20/1995 | EP0672155A1 A method for obtaining a plant having altered floral morphology and a method for protecting plants against pest insects |
| 09/20/1995 | EP0672154A1 A PROCESS FOR EXPRESSING GENES IN $i(BACILLUS LICHENIFORMIS) |
| 09/20/1995 | EP0672153A1 Vector to deliver and express foreign gene |
| 09/20/1995 | EP0672152A1 Fusion proteins comprising mgf and il-3 |
| 09/20/1995 | EP0672151A1 Inhibitors of ced-3 and related proteins |
| 09/20/1995 | EP0672150A1 Modified kluyveromyces yeasts, their preparation and use |
| 09/20/1995 | EP0672149A1 PROCESS FOR PRODUCING/SECRETING A PROTEIN BY A TRANSFORMED MOULD USING EXPRESSION/SECRETION REGULATING REGIONS DERIVED FROM AN $i(ASPERGILLUS) ENDOXYLANASE II GENE |
| 09/20/1995 | EP0672148A1 Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom |
| 09/20/1995 | EP0672147A1 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 09/20/1995 | EP0672146A1 Biocidal chitin binding proteins |
| 09/20/1995 | EP0672145A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/20/1995 | EP0672144A1 Interleukin-6 receptor antagonists |
| 09/20/1995 | EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 09/20/1995 | EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 09/20/1995 | EP0672141A1 Methods of preparing soluble, oligomeric proteins |
| 09/20/1995 | EP0672140A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 09/20/1995 | EP0672139A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 09/20/1995 | EP0672138A1 Chimeric factor viii |
| 09/20/1995 | EP0672137A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 09/20/1995 | EP0672136A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 09/20/1995 | EP0672135A1 A cell expressing a glutamate receptor |
| 09/20/1995 | EP0672134A1 Peptides useful for inducing tolerance |
| 09/20/1995 | EP0672133A1 TNF-$g(a) RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-$g(a) RIBOZYMES |
| 09/20/1995 | EP0672132A1 Receptor internalization signals |
| 09/20/1995 | EP0672131A1 Interaction trap system for isolating novel proteins |
| 09/20/1995 | EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 09/20/1995 | EP0672129A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins |
| 09/20/1995 | EP0672128A1 Stem cell proliferation factor |
| 09/20/1995 | EP0672124A1 Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene |
| 09/20/1995 | EP0672122A1 Oligonucleotides with rna cleavage activity |
| 09/20/1995 | EP0672120A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 09/20/1995 | EP0672119A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 09/20/1995 | EP0672118A1 A novel b-lymphoma cell line and antigen |
| 09/20/1995 | EP0672116A1 Deletion mutants as vaccines for cholera |
| 09/20/1995 | EP0672068A1 Target binding polypeptide |
| 09/20/1995 | EP0672067A1 Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof |
| 09/20/1995 | EP0672066A1 Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv |
| 09/20/1995 | EP0672065A1 Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv |
| 09/20/1995 | EP0672064A1 Op-3-induced morphogenesis |
| 09/20/1995 | EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 09/20/1995 | EP0672060A1 Antigen associated with type i diabetes mellitus |
| 09/20/1995 | EP0672057A1 Analogs of pth |
| 09/20/1995 | EP0672048A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
| 09/20/1995 | EP0671955A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
| 09/20/1995 | EP0671951A1 Humanized antibodies reactive with l-selectin |
| 09/20/1995 | EP0671946A1 Immunoreactive peptides from epstein-barr virus |